The US Food and Drug Administration wants COVID-19 vaccine developers to have plans for ensuring their clinical trials will continue after an emergency use authorization is granted and that product safety is actively followed in individuals vaccinated under an EUA.
A vaccine EUA request should include strategies that will be implemented to ensure ongoing trials are able to assess long-term...






